Compounds > n-(3-(aminomethyl)benzyl)acetamidine
Page last updated: 2024-10-21

n-(3-(aminomethyl)benzyl)acetamidine and Akinetic-Rigid Variant of Huntington Disease

n-(3-(aminomethyl)benzyl)acetamidine has been researched along with Akinetic-Rigid Variant of Huntington Disease in 1 studies

N-(3-(aminomethyl)benzyl)acetamidine: structure in first source
N-[3-(aminomethyl)benzyl]acetamidine : An aralkylamine that is Nbenzylacetamidine substituted at position 3 on the benzene ring by an aminomethyl group. An inhibitor of nitric oxide synthase.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chabrier, PE1
Demerlé-Pallardy, C1
Auguet, M1

Reviews

1 review available for n-(3-(aminomethyl)benzyl)acetamidine and Akinetic-Rigid Variant of Huntington Disease

ArticleYear
Nitric oxide synthases: targets for therapeutic strategies in neurological diseases.
    Cellular and molecular life sciences : CMLS, 1999, Volume: 55, Issue:8-9

    Topics: Alzheimer Disease; Amidines; Amyotrophic Lateral Sclerosis; Animals; Benzylamines; Brain Injuries; B

1999